Answer
Inbrija (inhaled levodopa) is used for intermittent treatment of episodic motor fluctuations (OFF episodes) in adults with Parkinson’s disease already treated with a levodopa/dopa-decarboxylase inhibitor.
Sources for this answer
- Inbrija 33mg inhalation powder, hard capsuleMerz Pharma UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked